Genus (GNS)

Sector:

Pharma and Biotech

Index:

FTSE 250

2,685.00p
   
  • Change Today:
    -10.00p
  • 52 Week High: 2,740.00
  • 52 Week Low: 1,424.00
  • Currency: UK Pounds
  • Shares Issued: 66.04m
  • Volume: 75,196
  • Market Cap: £1,773.11m
  • RiskGrade: 128
  • Beta: 0.01

Financial Analysis

Select chart: EPS | Dividend | Revenue

Key Fundamentals

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
30-Jun-21 574.30 55.80 100.90p 49.2 1.6 +30% 32.00p 0.6%
30-Jun-22 593.40 48.40 82.70p 30.3 n/a -18% 32.00p 1.3%
30-Jun-23 689.70 39.40 84.80p 25.5 12.8 +2% 32.00p 1.5%
30-Jun-24 668.80 5.50 65.50p 25.2 n/a -23% 32.00p 1.9%
30-Jun-25 672.80 28.50 81.80p 25.0 1.0 +25% 32.00p 1.6%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

Forecasts

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
30-Jun-26 699.90 86.16 89.03p 30.2 3.4 +9% 34.33p 0.0%
30-Jun-27 731.96 96.15 102.37p 26.2 1.7 +15% 37.45p 0.0%
30-Jun-28 769.23 106.97 117.65p 22.8 1.5 +15% 36.95p 0.0%

Copyright © 2025 FactSet Research Systems Inc. All rights reserved.

Price / Earnings Data

5 Yr High 5 Yr Low 5 Yr Avg Curr / Avg
Latest 49.16 25.00 31.04 1.06

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 6: Forecast figures based on normalised accounts.

 

IFRS Changes - Find Out More

Find out about IFRS and how this affects the financial infomation for all UK companies.

Genus Market Data

Currency UK Pounds
Share Price 2,685.00p
Change Today -10.00p
% Change -0.37 %
52 Week High 2,740.00
52 Week Low 1,424.00
Volume 75,196
Shares Issued 66.04m
Market Cap £1,773.11m
Beta 0.01
RiskGrade 128

Genus Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
92.49% below the market average92.49% below the market average92.49% below the market average92.49% below the market average92.49% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average
Price Trend
78.22% above the market average78.22% above the market average78.22% above the market average78.22% above the market average78.22% above the market average
90.91% above the sector average90.91% above the sector average90.91% above the sector average90.91% above the sector average90.91% above the sector average
Income
98.6% below the market average98.6% below the market average98.6% below the market average98.6% below the market average98.6% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average
Growth
91.76% below the market average91.76% below the market average91.76% below the market average91.76% below the market average91.76% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average

What The Brokers Say

Strong Buy 6
Buy 2
Neutral 0
Sell 1
Strong Sell 0
Total 9
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Genus Dividends

  Latest Previous
  Final Interim
Ex-Div 06-Nov-25 06-Mar-25
Paid 05-Dec-25 04-Apr-25
Amount 21.70p 10.30p

Trades for 10-Sep-2025

Time Volume / Share Price
15:05 0 @ 2,670.00p
16:35 34,165 @ 2,685.00p
16:35 169 @ 2,685.00p
16:35 132 @ 2,685.00p
16:35 66 @ 2,685.00p

Genus Key Personnel

CEO Jorgen Kokke
CFO Andy Russell

Top of Page